Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Thyroid peroxidase antibodies are associated with an increased risk of miscarriage and preterm birth, even when thyroid function is normal. Small trials indicate that the use of levothyroxine could reduce the incidence of such adverse outcomes. METHODS: We conducted a double-blind, placebo-controlled trial to investigate whether levothyroxine treatment would increase live-birth rates among euthyroid women who had thyroid peroxidase antibodies and a history of miscarriage or infertility. A total of 19,585 women from 49 hospitals in the United Kingdom underwent testing for thyroid peroxidase antibodies and thyroid function. We randomly assigned 952 women to receive either 50 μg once daily of levothyroxine (476 women) or placebo (476 women) before conception through the end of pregnancy. The primary outcome was live birth after at least 34 weeks of gestation. RESULTS: The follow-up rate for the primary outcome was 98.7% (940 of 952 women). A total of 266 of 470 women in the levothyroxine group (56.6%) and 274 of 470 women in the placebo group (58.3%) became pregnant. The live-birth rate was 37.4% (176 of 470 women) in the levothyroxine group and 37.9% (178 of 470 women) in the placebo group (relative risk, 0.97; 95% confidence interval [CI], 0.83 to 1.14, P = 0.74; absolute difference, -0.4 percentage points; 95% CI, -6.6 to 5.8). There were no significant between-group differences in other pregnancy outcomes, including pregnancy loss or preterm birth, or in neonatal outcomes. Serious adverse events occurred in 5.9% of women in the levothyroxine group and 3.8% in the placebo group (P = 0.14). CONCLUSIONS: The use of levothyroxine in euthyroid women with thyroid peroxidase antibodies did not result in a higher rate of live births than placebo. (Funded by the United Kingdom National Institute for Health Research; TABLET Current Controlled Trials number, ISRCTN15948785.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, there were insufficient data to perform a subgroup analysis of women with recurrent miscarriage, TPO antibodies and SCH.192”
From Recurrent MiscarriageGreen‐top Guideline No. 17 (2023) · cites this paper as [192]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., Grobman, W. A., Laurberg, P., Lazarus, J. H., Mandel, S. J., et al. (2017) · Thyroid® · doi:10.1089/thy.2016.0457 · Cited by 2,731
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Negro, R., Formoso, G., Mangieri, T., Pezzarossa, A., Dazzi, D., & Hassan, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1603 · Cited by 759
Thangaratinam, S., Tan, A., Knox, E., Kilby, M. D., Franklyn, J., & Coomarasamy, A. (2011) · BMJ · doi:10.1136/bmj.d2616 · Cited by 604
Self-citationWang, H., Gao, H., Chi, H., Zeng, L., Xiao, W., Wang, Y., Li, R., Liu, P., Wang, C., Tian, Q., et al. (2017) · JAMA · doi:10.1001/jama.2017.18249 · Cited by 236
Negro, R., Mangieri, T., Coppola, L., Presicce, G., Casavola, E. C., Gismondi, R., Locorotondo, G., Caroli, P., Pezzarossa, A., Dazzi, D., et al. (2005) · Human Reproduction · doi:10.1093/humrep/deh843 · Cited by 233
Research works printed but not linked: 2
- 2. NICE. Preterm labour and birth: guidance. Context. November 2015 (https:// www .nice .org .uk/ guidance/ ng25/ chapter/ context).
- 10. Fertility problems: assessment and treatment. NICE clinical guideline 156. - London: National Institute for Health and Care Excellence, 2013.
Cited by
Items 201–300 of 316
Recruitment prior to conception for pregnancy studies: a systematic review and meta-analysis
Kiley, J. X., Mitchell-Sparke, E., Cates, F. E., Mullins, E., Reynolds, R. M., & Aiken, C. (2026) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2026.01.035 · Cited by 1
Gao, J., Tian, T., Kayimu, K., Yuan, Y., Chen, Y., Fu, Y., Chen, R., Liu, F., Zhang, Y., & Wang, Y. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1860725 · Cited by 1
Walter, S. L., Chan, S., Raza, N., & Dhillon‐Smith, R. K. (2026) · Human Fertility · doi:10.1080/14647273.2026.2691185 · Cited by 1
Self-citationSchilddrüsenhormonsubstitution in der Schwangerschaft: Wann „lebenswichtig“, wann „Laborkosmetik“?
Minnemann, T., & Bullmann, C. (2019) · Der Gynäkologe · doi:10.1007/s00129-019-04503-3 · Cited by 1
Vanderpump, M. P. J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198851899.003.0001 · Cited by 1
The TABLET trial: limitations and implications
Dosiou, C., & Stagnaro‐Green, A. (2019) · BMC Medicine · doi:10.1186/s12916-019-1365-y · Cited by 1
Neff, K., Hunt, K., & Shawe, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-31753-9_10 · Cited by 2
Monsour, E. P., & Ospina, N. S. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.208-212 · Cited by 1
“The authors found that LT4 did not result in higher live birth rates as compared with placebo (12).”
Serény-Litvai, T., Bajnok, A., Temesfői, V., Nörenberg, J., Pham-Dobor, G., Kaposi, A., Várnagy, Á., Kovacs, K., Péntek, S., Kőszegi, T., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1039166 · Cited by 2
“However, a recent multi-centric, randomized, double-blind, placebo-controlled trial (TABLET) showed no positive effect of levothyroxine compared to placebo on the live-birth rate in euthyroid women with anti-TPO antibody positivity (10).”
BackgroundKojok, D., Ghazeeri, G. S., & Kutteh, W. H. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89907-9.00026-0 · Cited by 1
Katz, M. D. (2023) · Contemporary Endocrinology · doi:10.1007/978-3-031-19443-6_12 · Cited by 1
Schilddrüse und Schwangerschaft – Update 2023
Benker, G., & Rösler, S. (2023) · Frauenheilkunde up2date · doi:10.1055/a-1710-8889 · Cited by 1
“[21] Dhillon-Smith RK, Middleton LJ, Sunner KK et al.”
BackgroundThe evaluation and management of recurrent pregnancy loss
Bedaiwy, M. A., Elbasueny, B., Iews, M., Rowe, T., & Jiang, I. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85687-4.00017-8 · Cited by 1
Bhatt, S. J., Pinho, G., & Morelli, S. S. (2019) · Topics in Obstetrics & Gynecology · doi:10.1097/01.pgo.0000615660.61696.20 · Cited by 1
ASSOCIATION BETWEEN ANTI-THYROID PEROXIDASE ANTIBODY AND RECURRENT MISCARRIAGE
Mahmood, S., & Fattah, C. (2023) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10407 · Cited by 1
Schilddrüse und Schwangerschaft
Koehler, V. F., Auernhammer, C. J., & Spitzweg, C. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0660-6126 · Cited by 1
Opinion de comité no 407 : Pathologie thyroïdienne et infertilité
Donovan, L., Cockwell, H., Tallon, N., & Yamamoto, J. M. (2020) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.08.003 · Cited by 1
ERKRANKUNGEN DER ENDOKRINEN ORGANE UND DES STOFFWECHSELS
Jung, N., Mayet, W.-J., Mertens, P. R., Meyer, J. S., Müller, O.-A., Pfeifer, M., Schellinger, P. D., Weiss, N., & Wendtner, C.-M. (2020) · Elsevier eBooks · doi:10.1016/b978-3-437-06282-7.50015-2 · Cited by 1
Screening of Thyroid Function in Pregnancy
Azizi, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-98777-0_4 · Cited by 1
Korevaar, T. I. M. (2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.189-194 · Cited by 1
“From that point of view, it would be important to know whether TPOAb positivity was a risk factor for miscarriage as compared to TPOAb negativity in the TABLET trial (2, 12).”
Lee, S. Y. (2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.417-420
“A few randomized, controlled trials have not shown a clear benefit on infertility or pregnancy loss for thyroid hormone treatment in thyroid autoimmunity (5,6).”
Blomqvist, L. (2019) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Schilddrüse und Schwangerschaft
Frank‐Raue, K. (2019) · Der Klinikarzt · doi:10.1055/a-1061-0678
“Auch eine Reduktion der Abortrate oder Erhöhung der Geburtenrate konnte durch die Thyroxingabe bei Frauen mit TPO-Antikörpern, aber noch euthyreoter Stoffwechsellage nicht erreicht werden, das mediane TSH lag in dieser Studie bei 2,1 mIU/L (1,5– 2,7 mIU/l) [4].”
BackgroundFunzione tiroidea, concepimento e gravidanza: un dibattito aperto
Trimarchi, F., Bartalena, L., Fierabracci, P., Vermiglio, F., Vitti, P., & Chiovato, L. (2020) · L Endocrinologo · doi:10.1007/s40619-020-00723-1
Lee, S. Y. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.368-371
“Only a portion of patients with positive TPOAb titers in the TABLET trial had TSH values >2.5 mIU/L (8).”
InfluentialRostand, E. W. M., Sharpe, A., Mascarenhas, M., & Bhandari, H. M. (2020) · doi:10.22541/au.158456434.49298512
Thyroid imbalance and subfertility
Sheikh, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-75945-8.00009-8
Effect of Antithyroid Antibodies in the First Trimester on Pregnancy OutcomesPreprint
Xie, J., Huang, C.-C., Zhao, Q., Zhou, P., Jiang, L., Yu, D., Shen, Y., Feng, C., & Jin, M. (2021) · Research Square · doi:10.21203/rs.3.rs-146918/v1
Poppe, K. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-63277-9_4 · Cited by 2
Controlled ovarian hyperstimulation as a stress test for the thyroid
Korevaar, T. I. M., & de Keyser, C. E. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.04.025
Comparison of ATA and Updated ACOG Guidelines for Thyroid Disease in Pregnancy. Russian translation
Pearce, E. N. (2021) · Clinical and experimental thyroidology · doi:10.14341/ket12556
Schilddrüse und Schwangerschaft
Frank‐Raue, K. (2021) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-1430-4514
Zhou, P., Yao, Q., Yang, L., Yu, Y., Xie, J., Zhao, Q., Feng, C., Zhou, L., & Jin, M. Y. (2021) · Research Square · doi:10.21203/rs.3.rs-805694/v1
Hypothyroidism - A Causal Approach to Testing Assumptions against Empirical Results.
Glavin, R., Ness, R. O., & Nguyen, A. (2021) · PubMed
Disminución de los anticuerpos antitiroideos durante el embarazo en la tiroiditis de Hashimoto
Garmendia, F. (2021) · Revista Peruana de Ginecología y Obstetricia · doi:10.31403/rpgo.v67i2371
Zhou, P., Yao, Q., Yang, L., Yu, Y., Xie, J., Zhao, Q., Feng, C., Zhou, L., & Jin, M. Y. (2021) · Research Square · doi:10.21203/rs.3.rs-1071434/v1
Schübel, J., Voigt, K., & Bergmann, A. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-15280-1.00071-0
Payanes, R., Wang, A., & Yang, B. (2022) · Evidence-Based Practice · doi:10.1097/ebp.0000000000001502
General Considerations Relating to Thyroid Disease in Pregnancy
Taylor, P. N., Premawardhana, L. D. K. E., & Lazarus, J. H. (2022) · doi:10.1093/med/9780198870197.003.0170
Goeckenjan, M., & Strowitzki, T. (2022) · Gynäkologische Endokrinologie · doi:10.1007/s10304-022-00440-y
“und zuletzt eine groß angelegte RCT (TABLET-Studie [30]) zeigen jedoch”
Antenatal thyroid disease and pharmacotherapy in pregnancy
Clark, S. M., & Monsivais, L. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818902-3.00024-5 · Cited by 1
(2019) · Clinical Thyroidology · doi:10.1089/ct.2019;31.5-toc
Application of Selenium in Patients with Hypothyroidism during Pregnancy
曾, 超. (2020) · Advances in Clinical Medicine · doi:10.12677/acm.2020.107187
7 Medical Management of Thyroiditis and Hypothyroidism
(2021) · Thieme Medical Publishers eBooks · doi:10.1055/b-0041-182782
Neues und praktisch Relevantes in der gynäkologischen Endokrinologie und Reproduktionsmedizin
von Wolff, M., & Stute, P. (2020) · Gynäkologische Endokrinologie · doi:10.1007/s10304-020-00312-3
Effect of levothyroxine on pregnancy outcomes in euthyroid women with antithyroid antibodies
(2022) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2022.000028
Gigliotti, B. J. (2022) · Clinical Thyroidology · doi:10.1089/ct.2022;34.392-395
“…reviewed by Monsour and Singh Ospina (8), which along with the TABLET and POSTAL trials, questions the benefit of levothyrox-ine in improving fertility and miscarriage risk (specifically in anti-TPO antibody–positive women), even in subgroups of patients with TSH levels >2.5 µIU/ml (9, 10).”
InfluentialOptimal Management of the First Trimester in Women over 40
Cartwright, B., & Naik, A. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009025270.011
Thyroid autoimmunity and reproduction: Bidirectional relationship that continues to intrigue
Medenica, S., & Žarković, M. (2022) · Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma · doi:10.5937/mgiszm2287007m
Schilddrüsenerkrankungen in der Schwangerschaft
Bojunga, J., Güngöze, O., Hofbauer, L., & Müller, E. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1813-0892
Guo, J., Lu, Y., He, X., Li, J., Fan, C., Zhang, H., Teng, W., Shan, Z., & Li, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021021
“, the postal study and tablet study) have shown that L-thyroxine supplementation could not strongly prevent miscarriage, which suggests thyroid economy deficiency cannot completely account for the increased miscarriage risk in AIT females, especially in euthyroid women [14,15].”
BackgroundBliddal, S., & Feldt‐Rasmussen, U. (2023) · Clinical Thyroidology · doi:10.1089/ct.2023;35.12-14
“This was an observational study based on secondary analyses of the TABLET trial, in which euthyroid TPOAb-positive women with a history of infertility or pregnancy loss were randomly assigned to receive either 50 µg of LT4 daily (470 women) or placebo (470 women) (4).”
Frise, C., Bhalsod, K., Scott, R., & Gibson, H. W. (2023) · Oxford University Press eBooks · doi:10.1093/med/9780192845894.003.0011
Ceylan, Ş., & Yilmaz, N. (2023) · Current Medical Imaging Formerly Current Medical Imaging Reviews · doi:10.2174/1573405619666230209123957 · Cited by 1
Landmark Discoveries in Maternal–Fetal Thyroid Disease Over the Past Century
Leung, A. M. (2023) · Thyroid · doi:10.1089/thy.2022.0368
“83,84 Postpartum Thyroid Disease In the 1950s, Hazard described a variant of Hashimoto’s thyroiditis, characterized cytologically by extensive lymphocytic infiltration without epithelial oxyphilia 85 that was seen frequently in postpartum women.”
Evaluación diagnóstica y terapéutica de los abortos de repetición
García‐Franco, A. L., Prats, A. G., Corrochano, E. C., & Iglesias, A. P. (2023) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2022.11.003
Schübel, J., & Voigt, K. (2023) · Zeitschrift für Allgemeinmedizin · doi:10.1007/s44266-023-00053-z
Schilddrüse und Schwangerschaft
Koehler, V. F., Auernhammer, C. J., & Spitzweg, C. (2023) · Angewandte Nuklearmedizin · doi:10.1055/a-2030-6645
“Darin zeigte sich ebenfalls kein Effekt auf das primäre Outcome (Lebendgeburt nach mindestens 34 SSW) in der LT4-Behandlungsgruppe (n =467) im Vergleich zu Placebo (n =467) [7].”
BackgroundInfluentialPerinatology and reproductology: from research to practice
(2023) · Perinatology and reproductology from research to practice · doi:10.52705/2788-6190-2023-3
Alterazioni tiroidee nella fecondazione medicalmente assistita
Meomartino, L., Rossi, M., Giaccherino, R. R., & Pagano, L. (2023) · L Endocrinologo · doi:10.1007/s40619-023-01378-4
“Questi dati hanno portato gli esperti a ritenere AbTPO un fattore di rischio in-dipendente di alterata fertilità e di sviluppo di complicanze ostetriche [13].”
BackgroundDo elevated thyrotropin levels increase the risk of miscarriages: yes or no?
Barišić, T., Raguž, M. J., Šušak, I., Babić, E., Grgić, S., & Mandić, I. (2023) · The European Journal of Contraception & Reproductive Health Care · doi:10.1080/13625187.2023.2276031
“…significantly associated with adverse pregnancy outcomes in women with sch. levothyroxine treatment did not improve pregnancy outcomes regardless of tPO status [19, 20]. the european society of endocrinology recommends levothyroxine therapy for pregnant women with subclinical hypothyroidism [2].”
BackgroundFrequency and structure of thyroid disfunction is at gynaecological diseases
Netskar, I. (2023) · Perinatology and reproductology from research to practice · doi:10.52705/2788-6190-2023-03-8
Kumar, R., Roy, A., & Bharmal, V. S. (2023) · Springer eBooks · doi:10.1007/978-981-99-5423-0_5
Preconceptional Management of Thyroid Disease
Rashmi, K. G., & Sahoo, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-5423-0_2
Thyroid Autoimmunity and Pregnancy
Sridharan, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-5423-0_4
Pregnancy outcomes in women with subclinical hypothyroidism Treated with Levothyroxine
Mostafa, T. M., Abdel-Aziz, B. R., & Atta, A. O. A. (2023) · Al-Azhar International Medical Journal /Al-Azhar International Medical Journal · doi:10.58675/2682-339x.2121
Ago, B. U., Okpani, E., Abeshi, S. E., & Ekpe, L. E. (2024) · Prague Medical Report · doi:10.14712/23362936.2024.3
“However, Dhillon-Smith et al. (2019) in a randomized controlled trial involving 19,585 women in 49 hospitals in the United Kingdom failed to demonstrate significant difference in the pregnancy outcomes.”
BackgroundHormonelle Regulation des menstruellen Zyklus und ihre Störungen
Ludwig, M. Z., & Weiss, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-662-65517-7_3 · Cited by 1
Black, N., Quenby, S. M., & Odendaal, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2024-085929
Self-citationThyroid Function and Reproduction
Eliwa, J., Ke, R. W., & Kutteh, W. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21477-6.00234-0
Endocrine disorders in pregnancy
Chatterjee, B., & Chong, H. P. (2024) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2024.08.008
Tiroides y reproducción asistida
Sesmilo, G. (2024) · Endocrinología Diabetes y Nutrición · doi:10.1016/j.endinu.2024.10.001
Thyroid and assisted reproduction
Sesmilo, G. (2024) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2024.10.002
Schübel, J., Voigt, K., & Bergmann, A. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21029-7.00071-1
Risk factors for subclinical hypothyroidism in pregnant women in the 24 de Mayo canton, Ecuador
Fallaín, A. C., Macías, A. J., López, J., Cedeño, D. M., Chimbo, P. J., & Cedeño, J. A. (2024) · Health Leadership and Quality of Life · doi:10.56294/hl2024.40
Guidelines on the Diagnosis and Management of Sporadic Miscarriage
Oliver, A., & Overton, C. E. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.015
Self-citationDhillon-Smith, R. K., & Quenby, S. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009532549.010
Self-citationde Jonge, A., Verhoeven, C. J. M., Jong, E. F., van Dillen, J., & Bakker, P. (2025) · doi:10.1007/978-90-368-3142-0_2
Hintze, G., & Mann, K. (2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21184-3.00002-8
Raju, G. A. R., Sravani, P., Mahapatro, P., Kovvuri, A., Dave, V., Sharma, V., & Bunger, D. (2025) · Cureus · doi:10.7759/cureus.96633
Provinciatto, H. G., Barbalho, M. E., da Câmara, P. M., Bertani, M., Marinho, A. D., Philip, C. E., Balieiro, C. C. A., Pontes, K. F. M., & Júnior, E. A. (2025) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2025rbgo75
“(8) Given the potential implications of TPOAb during pregnancy, therapeutic interventions have been studied to avoid adverse outcomes.”
Bliddal, S., Ahmed, H. P., Nielsen, H. S., & Feldt-Rasmussen, U. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00168-0
Burlacu, M.-C., Attanasio, R., Hegedüs, L., Nagy, E. V., Papini, E., Perros, P., Sawadogo, K. A., Bex, M., Corvilain, B., Daumerie, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19313714
Wu, M., Chi, C., Yang, Y., Guo, S., Li, T., Gu, M., Zhang, T., Gao, H., Liu, R., & Yin, C. (2022) · Figshare · doi:10.6084/m9.figshare.20382003
Bein, M., Yu, O. H. Y., Grandi, S. M., Frati, F. Y. E., Kandil, I., & Filion, K. B. (2021) · Figshare · doi:10.6084/m9.figshare.14130758
Wu, M., Chi, C., Yang, Y., Guo, S., Li, T., Gu, M., Zhang, T., Gao, H., Liu, R., & Yin, C. (2022) · Figshare · doi:10.6084/m9.figshare.20382000
Wu, J., Peng, T., Xie, F., & Li, M.-Q. (2022) · Figshare · doi:10.6084/m9.figshare.20035586
Yang, X., Mu, F., Zhang, J., Yuan, L., Zhang, W., Yang, Y., & Wang, F. (2024) · Figshare · doi:10.6084/m9.figshare.26697632
Venables, A., Wong, W., Way, M., & Homer, H. A. (2020) · Figshare · doi:10.6084/m9.figshare.13290503
Burlacu, M.-C., Attanasio, R., Hegedüs, L., Nagy, E. V., Papini, E., Perros, P., Sawadogo, K. A., Bex, M., Corvilain, B., Daumerie, C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19313717
Berge, N. K. (2024) · heiDOK (Heidelberg University)
Suspected Type 2 Polyglandular Syndrome
Wei, J., & Chang, D. (2023) · eScholarship (California Digital Library)
Preconceptional thyroid autoimmunity, dysfunction and associated factors in nulliparous Indian women
Jayakumari, C., Valliyot, A., Babu, S., Nair, A., Bakshi, R. K., Jabbar, P. K., Kingsely, A., Sujatha, C., Anish, T., Nirmala, C., et al. (2025) · Thyroid Science · doi:10.1016/j.thscie.2025.100036
Sohn, S. Y., & Leung, A. M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00363-0
Qiu, Y., Qin, Z., Lin, J., & Yang, Y. (2026) · International Journal of Women s Health · doi:10.2147/ijwh.s580062
Pasquier, É., Martin, L. D. S., Marhic, G., Gal, G. L., Delluc, A., Pimentel, C., MEKINIAN, A., Chauleur, C., Plu‐Bureau, G., Bohec, C., et al. (2026) · The Lancet Obstetrics Gynaecology & Women s Health · doi:10.1016/s3050-5038(25)00207-9 · Cited by 2
Ferrari, E. H., & Nör, D. A. (2026) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
Silva-Edge, M., Elfituri, A., & Shehata, H. A. (2026) · Springer eBooks · doi:10.1007/978-3-032-23479-7_2
Athanasiadou, K. I., Peppa, Μ., Kalantaridou, S., & Paschou, S. Α. (2026) · Case Reports in Women s Health · doi:10.1016/j.crwh.2026.e00827
“The double-blind randomized controlled TABLET trial concluded that levothyroxine replacement in euthyroid women with positive TPOAb did not result in higher rate of live births compared with placebo (8).”
Goundan, P. N., & Lee, S. L. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-45863-7.00087-1
Metadata
- Authors
- Dhillon-Smith, R. K., Middleton, L. J., Sunner, K. K., Cheed, V., Baker, K., Farrell-Carver, S., Bender-Atik, R., Agrawal, R., Bhatia, K., Edi-Osagie, E., Ghobara, T., Gupta, P., Jurkovic, D., Khalaf, Y., MacLean, M., McCabe, C., Mulbagal, K., Nunes, N., Overton, C., Quenby, S., Rai, R., Raine-Fenning, N., Robinson, L., Ross, J., Sizer, A., Small, R., Tan, A., Underwood, M., Kilby, M. D., Boelaert, K., Daniels, J., Thangaratinam, S., Chan, S. Y., & Coomarasamy, A.
- Affiliations
- From the Institute of Metabolism and Systems Research (R.K.D.-S., C.M., M.D.K., K. Boelaert, A.C.), Tommy’s National Centre for Miscarriage Research (R.K.D.-S., A.C.), and the Birmingham Clinical Trials Unit, Institute of Applied Health Research (L.J.M., K.K.S., V.C., S.F.-C.), College of Medical and Dental Sciences, University of Birmingham, the Birmingham Women’s and Children’s NHS Foundation Trust (R.K.D.-S., L.R., M.D.K., A.C.), and University Hospital Birmingham (P.G., R.S.), Birmingham, the...
- Cancer Research UK Clinical Trials Unit (GB)
- University of Oxford (GB)
- Miscarriage Association (GB)
- University Hospital Coventry (GB)
- Burnley General Teaching Hospital (GB)
- St Mary's Hospital (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- University College Hospital (GB)
- Guy's and St Thomas' NHS Foundation Trust (GB)
- University Hospital Crosshouse (GB)
- Bolton NHS Foundation Trust (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- University Hospitals Bristol NHS Foundation Trust (GB)
- Imperial College Healthcare NHS Trust (GB)
- King's College Hospital NHS Foundation Trust (GB)
- Shrewsbury and Telford Hospital NHS Trust (GB)
- Queen Mary University of London (GB)
- University of Nottingham (GB)
- National University of Singapore (SG)
- ORCID
- Middleton, Lee J.
- Sunner, Kirandeep K.
- Cheed, Versha
- Baker, Krys
- Farrell-Carver, Samantha
- Bender-Atik, Ruth
- Agrawal, Rina
- Bhatia, Kalsang
- Edi-Osagie, Edmond
- Ghobara, Tarek
- Gupta, Pratima
- Jurkovic, Davor
- Khalaf, Yacoub
- MacLean, Marjory
- McCabe, Christopher
- Mulbagal, Khashia
- Nunes, Natalie
- Overton, Caroline
- Quenby, Siobhan
- Ross, Jackie
- Sizer, Andrew
- Small, Rachel
- Tan, Alex
- Underwood, Martyn
- Kilby, Mark D.
- Boelaert, Kristien
- Daniels, Jane
- Thangaratinam, Shakila
- Chan, Shiao Y.
- Coomarasamy, Arri
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-04-04
- Volume
- 380
- Issue
- 14
- Pages
- 1316-1325
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2925290838
- Cited by
- 303
- References
- 6
- Citations by year
- 2026: 20 · 2025: 21 · 2024: 35 · 2023: 45 · 2022: 65 · 2021: 40 · 2020: 50 · 2019: 27
- FWCI
- 36.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- New England Journal of Medicine (publishedVersion, other-oa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (publishedVersion, other-oa)
- Bristol Research (University of Bristol) (publishedVersion, other-oa)
- Warwick Research Archive Portal (University of Warwick) (acceptedVersion)
- Repository@Nottingham (University of Nottingham) (submittedVersion, cc-by)
- Funders
- Efficacy and Mechanism Evaluation Programme (09/100/10)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Keywords
- levothyroxine, thyroid peroxidase antibodies, thyroid autoantibodies, live birth rate, miscarriage, preterm birth, infertility, pregnancy outcomes, euthyroid women, adverse drug reactions
- MeSH terms
- Abortion, Spontaneous, Adult, Autoantibodies, Double-Blind Method, Female, Humans, Infertility, Female, Iodide Peroxidase, Pregnancy, Thyrotropin, Thyroxine, Preconception Care, Treatment Failure, Live Birth
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.